OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging role of natural products in cancer immunotherapy
Songtao Dong, Xiangnan Guo, Fei Han, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1163-1185
Open Access | Times Cited: 167
Songtao Dong, Xiangnan Guo, Fei Han, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1163-1185
Open Access | Times Cited: 167
Showing 26-50 of 167 citing articles:
An arabinose-rich heteropolysaccharide isolated from Belamcanda chinensis (L.) DC treats liver cancer by targeting FAK and activating CD40
Yinan Zhao, Jiantong Hou, Yuhui Liu, et al.
Carbohydrate Polymers (2024), pp. 121831-121831
Closed Access | Times Cited: 6
Yinan Zhao, Jiantong Hou, Yuhui Liu, et al.
Carbohydrate Polymers (2024), pp. 121831-121831
Closed Access | Times Cited: 6
CETSA-MS-based target profiling of anti-aging natural compound quercetin
Lin Bai, Zhifen Deng, Mengfei Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116203-116203
Closed Access | Times Cited: 6
Lin Bai, Zhifen Deng, Mengfei Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116203-116203
Closed Access | Times Cited: 6
Induction of ferroptosis by natural phenols: A promising strategy for cancer therapy
Yiping Zhang, Xie Jun
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 2041-2076
Closed Access | Times Cited: 6
Yiping Zhang, Xie Jun
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 2041-2076
Closed Access | Times Cited: 6
WTAP‐induced N6 ‐methyladenosine of PD‐L1 blocked T‐cell‐mediated antitumor activity under hypoxia in colorectal cancer
Qizhi Liu, Nan Zhang, Junyi Chen, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1749-1762
Open Access | Times Cited: 6
Qizhi Liu, Nan Zhang, Junyi Chen, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1749-1762
Open Access | Times Cited: 6
Phytochemicals in Drug Discovery - A Confluence of Tradition and Innovation
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
(2024)
Open Access | Times Cited: 6
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
(2024)
Open Access | Times Cited: 6
Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles
Muttiah Barathan, Ahmad Khusairy Zulpa, Sook Luan Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7470-7470
Open Access | Times Cited: 6
Muttiah Barathan, Ahmad Khusairy Zulpa, Sook Luan Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7470-7470
Open Access | Times Cited: 6
Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges
Xixi Wu, Xin Yuan, Hengtong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7415-7471
Open Access | Times Cited: 6
Xixi Wu, Xin Yuan, Hengtong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7415-7471
Open Access | Times Cited: 6
Orchestrated Metal-coordinated Carrier-free Celastrol Hydrogel Intensifies T Cell Activation and Regulates Response to Immune Checkpoint Blockade for Synergistic Chemo-immunotherapy
Linying Wu, Wenmin Pi, Huang Xuemei, et al.
Biomaterials (2024) Vol. 312, pp. 122723-122723
Closed Access | Times Cited: 6
Linying Wu, Wenmin Pi, Huang Xuemei, et al.
Biomaterials (2024) Vol. 312, pp. 122723-122723
Closed Access | Times Cited: 6
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
Kai Zeng, Weiwen Xie, Chunyu Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 15
Kai Zeng, Weiwen Xie, Chunyu Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 15
Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer
Baibai Ye, Ping Chen, Cheng Lin, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116815-116815
Closed Access | Times Cited: 14
Baibai Ye, Ping Chen, Cheng Lin, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116815-116815
Closed Access | Times Cited: 14
Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism
Wangqi Tian, Jumin Huang, Weitong Zhang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107034-107034
Open Access | Times Cited: 14
Wangqi Tian, Jumin Huang, Weitong Zhang, et al.
Pharmacological Research (2023) Vol. 199, pp. 107034-107034
Open Access | Times Cited: 14
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products
Lele Zhang, Du-Juan Zhang, Jia-Xin Shi, et al.
Phytomedicine (2024) Vol. 132, pp. 155828-155828
Closed Access | Times Cited: 4
Lele Zhang, Du-Juan Zhang, Jia-Xin Shi, et al.
Phytomedicine (2024) Vol. 132, pp. 155828-155828
Closed Access | Times Cited: 4
Phytocompounds and Nanoformulations for Anticancer Therapy: A Review
Giuseppina Bozzuto, Annarica Calcabrini, Marisa Colone, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3784-3784
Open Access | Times Cited: 4
Giuseppina Bozzuto, Annarica Calcabrini, Marisa Colone, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3784-3784
Open Access | Times Cited: 4
The molecular mechanism of gemcitabine in inhibiting the HIF-1α/VEGFB/FGF2/FGFR1 signaling pathway for ovarian cancer treatment
Liangliang Wang, Shanshan Ma, H. Su, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Liangliang Wang, Shanshan Ma, H. Su, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Tumor Microenvironment Targeted by Polysaccharides in Cancer Prevention: Expanding Roles of Gut Microbiota and Metabolites
Shuai Han, Yixin Luo, Zuomin Hu, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Shuai Han, Yixin Luo, Zuomin Hu, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
A comprehensive insights of cancer immunotherapy resistance
Laavanya Das, Subhadip Das
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
Laavanya Das, Subhadip Das
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access
A review on polysaccharide-based tumor targeted drug nanodelivery systems
Liangxing Tu, Banghuai Xing, Shenglin Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 140820-140820
Closed Access
Liangxing Tu, Banghuai Xing, Shenglin Ma, et al.
International Journal of Biological Macromolecules (2025), pp. 140820-140820
Closed Access
CNPY2 expression as a diagnostic and prognostic biomarker in non-small cell lung cancer
Jiang Xiao, Jun Chen, Shujun Ding, et al.
Clinical Biochemistry (2025), pp. 110895-110895
Closed Access
Jiang Xiao, Jun Chen, Shujun Ding, et al.
Clinical Biochemistry (2025), pp. 110895-110895
Closed Access
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access
Molecular insights into the antineoplastic potential of apigenin and its derivatives: paving the way for nanotherapeutic innovations
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Debasmita Dutta, Ashique Al Hoque, Brahamacharry Paul, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Machine learning-based identification of telomere-related gene signatures for prognosis and immunotherapy response in hepatocellular carcinoma
Zhengmei Lu, Xiaowei Chai, Shibo Li
Molecular Cytogenetics (2025) Vol. 18, Iss. 1
Open Access
Zhengmei Lu, Xiaowei Chai, Shibo Li
Molecular Cytogenetics (2025) Vol. 18, Iss. 1
Open Access
New advances of natural products in non-small cell lung cancer: from mechanisms to therapies
Yuening Yang, Haolei Wang, Qianqian Xue, et al.
Journal of Ethnopharmacology (2025), pp. 119636-119636
Closed Access
Yuening Yang, Haolei Wang, Qianqian Xue, et al.
Journal of Ethnopharmacology (2025), pp. 119636-119636
Closed Access
